ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,701.70
0.96%
S&P ASX All Technology
3,075.00
0.84%
Brent Oil
81.295
0.00%
US Dollar vs AUD
1.49858
0.00%
Bitcoin
67,744.23
0.03%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ophthotech Corp. (OPHT)

  7. Ophthotech Corp. (OPHT) News

OPHT

OPHTHOTECH CORP. (OPHT)

Ophthotech Corp.
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OPHT
DateTimeSourceHeadlineSymbolCompany
18/04/201920:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OPHTOphthotech Corp.
17/04/201906:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPHTOphthotech Corp.
16/04/201921:30Business WireOphthotech Transitions to a Gene Therapy Focused Company Developing Treatments for Orphan Inherited Retinal Diseases & Change...NASDAQ:OPHTOphthotech Corp.
12/04/201906:52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPHTOphthotech Corp.
12/04/201906:05Business WireOphthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal DiseasesNASDAQ:OPHTOphthotech Corp.
04/04/201909:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPHTOphthotech Corp.
14/03/201923:00Business WireOphthotech to Present at the Alliance for Regenerative Medicine’s (ARM) 7th Annual Cell & Gene Therapy Investor DayNASDAQ:OPHTOphthotech Corp.
07/03/201900:00Business WireOphthotech to Present at the Cowen and Company 39th Annual Health Care ConferenceNASDAQ:OPHTOphthotech Corp.
01/03/201922:30Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OPHTOphthotech Corp.
01/03/201909:38Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OPHTOphthotech Corp.
01/03/201909:37Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OPHTOphthotech Corp.
26/02/201923:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPHTOphthotech Corp.
26/02/201923:15Business WireOphthotech Reports Fourth Quarter and Full Year 2018 Financial and Operating ResultsNASDAQ:OPHTOphthotech Corp.
20/02/201900:00Business WireOphthotech Corp. to Report Fourth Quarter & Full Year 2018 Financial Results & Host Conference Call on Tuesday, February 26, ...NASDAQ:OPHTOphthotech Corp.
15/02/201908:26Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OPHTOphthotech Corp.
15/02/201906:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OPHTOphthotech Corp.
14/02/201908:47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OPHTOphthotech Corp.
13/02/201922:08Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OPHTOphthotech Corp.
07/02/201903:53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OPHTOphthotech Corp.
17/01/201906:30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPHTOphthotech Corp.
08/01/201900:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPHTOphthotech Corp.
07/01/201923:56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPHTOphthotech Corp.
05/01/201910:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPHTOphthotech Corp.
05/01/201910:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPHTOphthotech Corp.
04/01/201909:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPHTOphthotech Corp.
04/01/201909:37Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OPHTOphthotech Corp.
04/01/201900:00Business WireOphthotech Corporation to Present at the 37th Annual J.P. Morgan Healthcare ConferenceNASDAQ:OPHTOphthotech Corp.
03/01/201900:00Business WireOphthotech Announces the Addition of Ophthalmic Industry Leader, Calvin (Cal) W. Roberts, M.D., to Its Board of DirectorsNASDAQ:OPHTOphthotech Corp.
15/12/201809:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPHTOphthotech Corp.
15/12/201809:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPHTOphthotech Corp.
 Showing the most relevant articles for your search:NASDAQ:OPHT

Your Recent History

ASX
CSL
CSL
FX
AUDJPY
AUD vs Yen
ASX
XTO
S&P ASX 100
NASDAQ
AMZN
Amazon.com
ASX
MQG
Macquarie
NYSE
MRK
Merck
ASX
WBC
Westpac Banking
NYSE
VZ
Verizon Communications
ASX
XJO
S&P ASX 200
ASX
TLS
Telstra
ASX
XAO
Australian SE All Ordina...
NYSE
DIS
Walt Disney
ASX
CBA
Commonwealth Bank Of Aus...
NASDAQ
NVDA
NVIDIA
NASDAQ
MSFT
Microsoft
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved